News: Brokerage

JLL relocates Syneos Health to 86,498 s/f at Brookfield Place

Manhattan, NY JLL has completed a new transaction for Syneos Health at 200 Vesey St. The biopharmaceutical solutions organization signed a lease for 86,498 s/f inside a commercial office condominium within the class A, 2.5 million s/f office building at Brookfield Place.

Syneos Health was represented by Erika Jean McNeil, Jonathan Fanuzzi and Kip Orban, key members of the brokerage group led by Paul Glickman and Matt Astrachan. The team worked closely with Kevin Brandenburg, senior vice president and head of corporate services, at Syneos Health on the transaction. The owner was represented by Lisa Kiell, Michael Shenot, Ed DiTolla and Andrew Coe, also with JLL.

Syneos Health signed a 10-year lease for the space and will occupy the entire 39th and 40th floors at 200 Vesey St., uniting operations from multiple locations in the borough. Relocating to 200 Vesey St. included negotiating complex termination agreements from multiple locations.

“Syneos Health was looking for a large block of high-end office space in Manhattan that would allow the company to bring multiple parts of its business together under one roof,” said McNeil. “The new flagship space supports the company’s cultural and business needs, providing two exclusive floors in a premiere building where employees can work together in a collaborative environment with state-of-the art technology and amenities. Employees and biopharmaceutical customers alike will also benefit from access to the Oculus, one of the world’s premiere transportation hubs.”  

Owned by Brookfield Properties, 200 Vesey St. is located at the intersection of Vesey and West Sts. at the north end of the Cesar Pelli-designed Brookfield Place. Completed in 1986, the 53-story office tower has more than 2.1 million s/f of rentable area, including 300,000 s/f of retail and dining.

READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

July 1, 2025 is the deadline for US banks to begin to adopt Basel III banking standards and July 14, 2025 is the deadline for U.S. banks to adopt ISO 20022 messaging standards. Both will have a significant effect on the banking and commercial real estate (CRE) finance sectors.
A fresh start - by Shallini Mehra and Amit Doshi

A fresh start - by Shallini Mehra and Amit Doshi

For the past several years, the New York City multifamily housing market has been defined by disruption. The combined impact of the HSTPA rent laws and a sharply higher interest rate environment has fundamentally reduced
Tri-state capital  migrates nationally amid  regulation pressure - by Reese Weaver

Tri-state capital migrates nationally amid regulation pressure - by Reese Weaver

New York tri-state multifamily investors are increasingly reallocating capital to less-regulated markets across the U.S. as rent control and legislative risk erode returns at home. With over 60% of New York City’s rental housing stock classified as rent-stabilized, the traditional value-add model — buying under-performing buildings,

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

There was a time when an offering memorandum (OM) was pretty bare bones, some photos, a few bullet points on income, and a rent roll thrown in at the back. That used to get the job done. Not anymore. In 2025, buyers are sharper, faster, and more selective. They’re looking